Rhinitis (Ear Nose Throat Disorders) - Drugs in Development, 2021
Summary Rhinitis (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Rhinitis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Rhinitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rhinitis and features dormant and discontinued projects.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope - The report provides a snapshot of the Global Therapeutic Landscape of Rhinitis (Ear Nose Throat Disorders). - The report reviews pipeline therapeutics for Rhinitis (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. - The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. - The report reviews key players involved in the development of Rhinitis (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects. - The report assesses Rhinitis (Ear Nose Throat Disorders) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. - The report summarizes all the dormant and discontinued pipeline projects. - The report reviews latest news related to pipeline therapeutics for Rhinitis (Ear Nose Throat Disorders).
Reasons to Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Identify and understand important and diverse types of therapeutics under development for Rhinitis (Ear Nose Throat Disorders). - Identify potential new clients or partners in the target demographic. - Develop strategic initiatives by understanding the focus areas of leading companies. - Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it’s most promising pipeline therapeutics. - Devise corrective measures for pipeline projects by understanding Rhinitis (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Our reports have been used by over 10K customers, including:
Medical technology (MedTech) firms are on the verge of reinventing their role in enabling care delivery due to various external factors, such as continuous margin pressures from providers on account of increasing healthcare costs, changing needs of end users, rapid technological advancements, empowered patient-consumers taking an active role...
Help on demand: A growing elderly population will likely continue to boost the number of emergency visits Abstract Ambulance Services in the US The Ambulance Services industry exhibited growth over the five years to 2019, driven by demographic shifts. Over the five years to 2024, industry revenue is...
The specialty vehicle market was valued at around USD 92.28 billion in 2020, and it is likely to reach USD 113.21 billion by 2026, anticipating a CAGR of 3.18% during the forecast period (2021-2026). - The economic growth in the later half of past decade (2010 - 2019) has led to the global diversification and initiation of many businesses...
KEY FINDINGS The North America anesthesia machinery market is projected to grow at a CAGR of 6.52% during the forecast period, 2021-2028. The surging number of surgical procedures and the growing prevalence of diseases are set to propel market growth. MARKET INSIGHTS The North America anesthesia...
KEY FINDINGS The North America patient experience management market is estimated to project a CAGR of 17.09% during the forecast period, 2021-2028. Partnerships and product launches have raised the competition in the market. Patient satisfaction has become a priority in the region in the last decade, with healthcare regulators...
Apple a day: Many operators will likely engage in mergers and acquisitions to achieve economies of scale Abstract Healthcare and Social Assistance in the US The Healthcare and Social Assistance sector has steadily grown over the past five years. The majority of services offered by subsectors in the...
Abstract Medical Supplies Manufacturing in China The Medical Supplies Manufacturing industry in China comprises manufacturers of supplementary and supporting materials and supplies for surgery and dentistry, such as medical fillers, surgical dressings, suturing materials, bandages, absorbable hemostatic materials,...
440 pages •
By Global Industry Analysts
• Apr 2021
- As a Hidden Health Crisis of COVID-19 Takes Shape, Routine Healthcare Services Must Resume. Otoscopes to Reach $204Million
- Global market for Otoscopes is expected to reach US$204.3 million by the year 2027 trailing a post pandemic growth rate of 3.2% for the period 2020 to 2027. During the early part...
366 pages •
By Global Industry Analysts
• Apr 2021
- Global Ligation Devices Market to Reach $1.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Ligation Devices estimated at US$944.8 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 5.2% over the period 2020-2027. Accessories,...
Helping hands: The outbreak of COVID-19 has increased industry funding and revenue Abstract Crisis and Care Accommodation in Australia The industry provides residential care accommodation (except aged care) combined with nursing, supervisory or other types of care as required (including medical). This...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.